Proteomics Intl Labs Ltd has released a press release.
PromarkerD clinical assay performance results published
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Earlier from Proteomics International Laboratories
- Proteomics receives $1.1 million in R&D tax incentive
- Completion of Placement and Appendix 2A
- September 2020 Quarterly Activities Report and Appendix 4C
- Proteomics International raises $6m in successful Placement
- First distribution agreement for PromarkerD immunoassay
Later from Proteomics International Laboratories
- Middle East is next market for PromarkerD immunoassay test
- AGM Investor Presentation
- December 2020 Quarterly Activities Report and Appendix 4C
- Proteomics International seeks FDA approval for PromarkerD
- Response to Price Query
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories